국가: 미국
언어: 영어
출처: NLM (National Library of Medicine)
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV)
Meitheal Pharmaceuticals Inc.
INTRAVENOUS
PRESCRIPTION DRUG
Phenylephrine Hydrochloride Injection 10 mg per mL is indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the settings of anesthesia and septic shock. The use of phenylephrine hydrochloride injection 10 mg per mL is contraindicated in patients with: - Hypersensitivity to the products or any of their components Risk Summary In animal reproductive and developmental studies, decreased fetal body weights were noted at 0.4 times the human daily dose (HDD) of 10 mg. No malformations were reported, however, an increased incidence of agenesis of the intermediate lobe of the lung, a visceral variation, was reported at levels as low as 0.08 times the HDD. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and misca
Phenylephrine Hydrochloride Injection, USP, 10 mg per mL, is supplied as follows: Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Protect from light. Keep covered in carton until time of use. The 1 mL vials are for single-dose only. The diluted solution should not be held for more than 4 hours at room temperature or for more than 24 hours under refrigerated conditions (2° to 8°C). Discard any unused portion. Sterile, Nonpyrogenic. The container closure is not made with natural rubber latex.
Abbreviated New Drug Application
PHENYLEPHRINE HYDROCHLORIDE- PHENYLEPHRINE HYDROCHLORIDE INJECTION MEITHEAL PHARMACEUTICALS INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE PHENYLEPHRINE HYDROCHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR PHENYLEPHRINE HYDROCHLORIDE INJECTION. PHENYLEPHRINE HYDROCHLORIDE INJECTION, FOR INTRAVENOUS USE INITIAL U.S. APPROVAL: 2012 RECENT MAJOR CHANGES Indications and Usage (1) 03/2023 Dosage and Administration (2.1, 2.2) 03/2023 INDICATIONS AND USAGE Phenylephrine Hydrochloride Injection 10 mg per mL is alpha-1 adrenergic receptor agonist indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the settings of anesthesia and septic shock. (1) DOSAGE AND ADMINISTRATION Phenylephrine Hydrochloride Injection 10 mg per mL: MUST BE DILUTED before administration. (2.1) _Dosing for Perioperative Hypotension_ – – _Dosing for Patients with Vasodilatory Shock_ – DOSAGE FORMS AND STRENGTHS Phenylephrine Hydrochloride Injection: 10 mg in 1 mL (10 mg per mL) of phenylephrine hydrochloride in a single-dose vial (3) CONTRAINDICATIONS Hypersensitivity to the products or any of their components (4) WARNINGS AND PRECAUTIONS Severe bradycardia and decreased cardiac output: (5.2) Extravasation: during intravenous administration may cause necrosis or sloughing of tissue (5.4) Concomitant use with oxytocic drugs: pressor effect of sympathomimetic pressor amines is potentiated (5.5) Allergic-type reactions with phenylephrine hydrochloride injection 10 mg per mL: Sulfite (5.6) ADVERSE REACTIONS Most common adverse reactions: nausea and vomiting, headache, nervousness (6) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT MEITHEAL PHARMACEUTICALS INC. AT 1-844- 824-8426 OR FDA AT 1-800-FDA-1088 OR WWW.FDA.GOV/MEDWATCH. DRUG INTERACTIONS Agonistic effects with monoamine oxidase inhibitors (MAOI), β-adrenergic blocking agents, α-2 adrenergic agonists, steroids, t 전체 문서 읽기